Australian tech stocks have been under pressure recently. Concerns about interest rates, valuations, and the potential disruptive impact of artificial intelligence (AI) on parts of the software industry have weighed on sentiment.
However, market pullbacks can sometimes create opportunities for long-term investors.
When high-quality stocks sell off alongside the broader sector, patient investors may be able to pick up strong businesses at more attractive prices.
With that in mind, here are three excellent Australian tech stocks that analysts think could be worth considering before sentiment improves.
Pro Medicus Ltd (ASX: PME)
The first Australian tech stock that could be ready to rebound is Pro Medicus.
Pro Medicus develops advanced medical imaging software used by hospitals and healthcare providers around the world. Its Visage platform enables radiologists to process and analyse complex medical scans much faster than traditional systems, improving efficiency and clinical outcomes.
The company’s incredible growth over the past decade has been driven by long-term contracts with major hospital networks. Once its platform is installed, switching providers can be difficult, which creates strong customer retention and recurring revenue.
Medical imaging volumes continue to grow as healthcare systems become more data-driven and diagnostic demand increases. With a strong pipeline of hospital tenders, a reputation for best-in-class technology, and expansion into other ologies, Pro Medicus still appears to have a very long growth runway.
Morgans currently rates Pro Medicus as a buy with a $275.00 price target.
TechnologyOne Ltd (ASX: TNE)
Another Australian tech stock that could bounce back strongly is TechnologyOne.
TechnologyOne provides enterprise software to government agencies, universities, and large organisations. Its cloud platform helps customers manage finance, payroll, asset management, and other critical systems.
Over recent years, the company has successfully transitioned its business toward a software-as-a-service model. This shift has increased recurring revenue and improved earnings visibility.
With the ongoing migration to the cloud and new AI-driven features being added to its software suite, the company appears well positioned to continue growing over the long term.
Ord Minnett recently put a buy rating and $30.54 price target on its shares.
WiseTech Global Ltd (ASX: WTC)
A third Australian tech stock that could rebound is WiseTech Global.
WiseTech develops logistics software used by freight forwarders, shipping companies, and supply chain operators around the world. Its CargoWise platform helps manage the complex movement of goods across borders, customs systems, and transportation networks.
Global trade is becoming increasingly digital, and logistics companies rely on sophisticated software platforms to manage compliance, documentation, and operations. WiseTech’s CargoWise system has become a critical tool for many large freight operators.
Looking ahead, the opportunity tied to the digitalisation of global trade remains substantial, which bodes well for its growth outlook.
Bell Potter has a buy rating and $83.75 price target on its shares.
The post 3 excellent Australian tech stocks to buy before they rebound appeared first on The Motley Fool Australia.
Should you invest $1,000 in Pro Medicus right now?
Before you buy Pro Medicus shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Pro Medicus wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Is the Pro Medicus share price an opportunity too good to pass up?
- Beaten down: Are Cochlear, Pro Medicus or CSL shares a better buy right now?
- Here are the top 10 ASX 200 shares today
- $5,000 to invest? Here’s how I’d split it across the ASX
- I’d listen to Warren Buffett and buy quality ASX shares at fair prices today
Motley Fool contributor James Mickleboro has positions in Pro Medicus, Technology One, and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Pro Medicus and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.